The increased expression of the pro-inflammatory factors MIP-1α and IL-8 by FP ICC are consistent with the inflammatory response associated with mild to severe PFO and decrease in cell viability seen on days 7 and 14 post-transplantation respectively (Table 1 & Figure 2). The gene discussed is CCL3; the disease is Patent foramen ovale.